|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-7-23
|
|
pubmed:abstractText |
A new galenic form of cyclosporin A has been developed, based on microemulsion technology. The bioavailability of the compound is relatively independent of food intake and bile flow. It was the purpose of this prospective clinical trial to study the safety of the microemulsion form of cyclosporin A.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
165-72
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8649628-Administration, Oral,
pubmed-meshheading:8649628-Adult,
pubmed-meshheading:8649628-Aged,
pubmed-meshheading:8649628-Aspartate Aminotransferases,
pubmed-meshheading:8649628-Biopsy,
pubmed-meshheading:8649628-Blood Pressure,
pubmed-meshheading:8649628-Creatinine,
pubmed-meshheading:8649628-Cyclosporine,
pubmed-meshheading:8649628-Emulsions,
pubmed-meshheading:8649628-Female,
pubmed-meshheading:8649628-Graft Rejection,
pubmed-meshheading:8649628-Humans,
pubmed-meshheading:8649628-Immunosuppressive Agents,
pubmed-meshheading:8649628-Kidney Transplantation,
pubmed-meshheading:8649628-Male,
pubmed-meshheading:8649628-Middle Aged,
pubmed-meshheading:8649628-Prospective Studies,
pubmed-meshheading:8649628-Uric Acid
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
|
|
pubmed:affiliation |
Department of Medicine-Nephrology, University Hospital Charité, Humboldt University of Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
